Osteotech stops polymer research:
This article was originally published in Clinica
Osteotech has discontinued its polymer R&D programme which included the development of an adhesion barrier and an artificial skin product. Furthermore, the company has stopped marketing its OsteoActive bone substitute. The bone void filler was launched in Europe in late 1995. The measures are part of a restructuring programme to cut spending by more than $1 million a year and to make the European operations profitable. Osteotech will focus on building its revenues by producing ceramic and titanium plasma spray coating services and ceramic powders and products.